In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
She brings extensive expertise in managing global and domestic procurement operations
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
Profit after tax took a sharp hit, falling to Rs. 33 Cr in Q4 FY26, down from Rs. 106 Cr in Q4 FY25 and Rs. 52 Cr in Q3 FY26
The company reported free cash flow of Rs. 2,590 Mn for FY26
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Subscribe To Our Newsletter & Stay Updated
